Baxter (NYSE:BAX) is pulling back 2 lots of its peritoneal dialysis solution over concerns that the product may have been contaminated during the manufacturing process.
There have been no reports yet of any injuries associated with the affected lots but Baxter is preemptively asking customers to locate and return the products, which were distributed between May 30 and July 19 this year.
The recalled lots, which represent less than 1% of Baxter’s annual dialysis product, may have come into contact with "stainless steel, garment fiber, and PVC particulate matter identified during the manufacturing process," according to an FDA memo.
"To date, no adverse events or related product complaints have been associated with the recalled products, which were distributed to dialysis centers, facilities, distributors, and patients in the United States," the agency noted.
